🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 23 of 78

  1. US 10280307

    Class of stable heptamethine cyanine fluorophores and biomedical applications thereof

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10273299

    Antibodies to tumor endothelial marker 8

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10272163

    Factor VIII mutation repair and tolerance induction

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10273288

    Neutralizing antibodies to Ebola virus glycoprotein and their use

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10273291

    Focused evolution of HIV-1 neutralizing antibodies revealed by crystal structures and deep sequencing

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10272039

    Topical sodium nitrite formulation

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10265313

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10266565

    Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10265368

    Date pit composition for the treatment of animals

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10265382

    Complexes of IL-15 and IL-15Ralpha and uses thereof

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10266488

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10260054

    Engineered organophosphorus acid anhydrolases and methods of use thereof

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10258686

    Materials and methods for respiratory disease control in canines

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10258682

    Attenuated chlamydia vaccine

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10258701

    Labeled evans blue dye derivative for in vivo serum albumin labeling

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10251912

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10246505

    Chimeric antigen receptors to control HIV infection

    Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10246463

    Hypoxia-inducible factor 1 (HIF-1) inhibitors

    Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10246514

    Single domain antibodies that bind to human CD20

    Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10239830

    Benzenesulfonamide upregulators of NPC1 for Neimann-Pick disease and other lysosomal storage disorders

    Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10238618

    Compositions and methods for diagnosis and treatment of anemia

    Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10233209

    Inhibitors of the farnesoid x receptor and uses in medicine

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10227395

    Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10220103

    Magnetic microstructures for magnetic resonance imaging

    Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10220028

    Thio compounds

    Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10215825

    Magnetic microstructures for magnetic resonance imaging

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10213445

    Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10214732

    Lysin agent and method of use for diagnostic testing

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10214726

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10208100

    Angiopoietin-2 specific TIE2 receptor

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10208035

    Compounds for inhibiting drug-resistant strains of HIV-1 integrase

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10206957

    Use of gram negative species to treat atopic dermatitis

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10206995

    Live attenuated virus vaccines for la crosse virus and other bunyaviridae

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10208111

    Alpha-synuclein antibodies and uses thereof

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10202367

    Heterocyclic compounds and methods of use thereof

    Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10201499

    Nanoparticle formulation

    Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10201591

    TSLP induces neutrophil mediated killing of methicillin-resistant staphylococcus aureus

    Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10202631

    Multi-tiered, high through-put screen for compounds effective against bacterial biofilm compounds effective for inhibiting and eradicating bacterial biofilm

    Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10196616

    Altered avian virus for in-ovo inoculation and methods of use thereof

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10196372

    MYC G-quadruplex stabilizing small molecules and their use

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10196596

    Engineered lumenized vascular networks and support matrix

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10196603

    Aligned and electrospun piezoelectric polymer fiber assembly and scaffold

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10196612

    Method of characterizing and manipulating adipose stem cell depots to a metabolically healthy state

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10195236

    Use of gram negative species to treat atopic dermatitis

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10197577

    Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10196443

    TEM8 antibodies and their use in treatment and detection of tumors

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10188755

    Magnetic microstructures for magnetic resonance imaging

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10189878

    Ebolavirus pre-hairpin intermediate mimics and methods of use

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.